Stay updated with breaking news from Bio Daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Chardan Capital assumed coverage on shares of iBio (NYSE:IBIO – Free Report) in a report released on Tuesday, MarketBeat.com reports. The brokerage issued a buy rating and a $5.00 price target on the stock. Separately, StockNews.com started coverage on iBio in a research note on Saturday, April 20th. They issued a sell rating for the […]
IBio, Inc. (NYSEAMERICAN:IBIO – Get Free Report) was the target of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 161,700 shares, a growth of 172.7% from the March 15th total of 59,300 shares. Approximately 1.9% of the company’s shares are short sold. Based […]
StockNews.com started coverage on shares of iBio (NYSE:IBIO – Free Report) in a research report released on Thursday. The brokerage issued a sell rating on the stock. iBio Stock Down 15.3 % iBio stock opened at $2.11 on Thursday. The company has a debt-to-equity ratio of 0.04, a current ratio of 0.91 and a quick […]
Stock analysts at StockNews.com initiated coverage on shares of iBio (NYSEAMERICAN:IBIO – Get Free Report) in a report issued on Wednesday. The brokerage set a “sell” rating on the stock. iBio Stock Up 20.8 % IBIO opened at $4.06 on Wednesday. iBio has a 1-year low of $1.02 and a 1-year high of $49.00. The […]
Fermata Advisors LLC bought a new stake in shares of INmune Bio, Inc. (NASDAQ:INMB – Free Report) during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 56,702 shares of the company’s stock, valued at approximately $384,000. A number of other […]